Search Results
You are looking at 1 - 3 of 3 items for
- Author: Simona Pisanti x
- Refine by access: All content x
Search for other papers by Maurizio Bifulco in
Google Scholar
PubMed
Search for other papers by Anna Maria Malfitano in
Google Scholar
PubMed
Search for other papers by Simona Pisanti in
Google Scholar
PubMed
Search for other papers by Chiara Laezza in
Google Scholar
PubMed
The ‘endocannabinoid system’, comprising the cannabinoid CB1 and CB2 receptors, their endogenous ligands, endocannabinoids and the enzymes that regulate their biosynthesis and degradation, has drawn a great deal of scientist attention during the last two decades. The endocannabinoid system is involved in a broad range of functions and in a growing number of physiopathological conditions. Indeed, recent evidence indicates that endocannabinoids influence the intracellular events controlling the proliferation of numerous types of endocrine and related cancer cells, thereby leading to both in vitro and in vivo antitumour effects. In particular, they are able to inhibit cell growth, invasion and metastasis of thyroid, breast and prostate tumours. The chief events of endocannabinoids in cancer cell proliferation are reported highlighting the correspondent signalling involved in tumour processes: regulation of adenylyl cyclase, cyclic AMP-protein kinase-A pathway and MEK-extracellular signal-regulated kinase signalling cascade.
Istituto di Endocrinologia e Oncologia Sperimentale, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Dipartimento di Scienze Farmaceutiche, Consiglio Nazionale delle Ricerche, Napoli, Italy
Search for other papers by Chiara Laezza in
Google Scholar
PubMed
Search for other papers by Simona Pisanti in
Google Scholar
PubMed
Search for other papers by Anna Maria Malfitano in
Google Scholar
PubMed
Search for other papers by Maurizio Bifulco in
Google Scholar
PubMed
The endocannabinoid system regulates cell proliferation and migration in human breast cancer cells. In this study, we showed that a metabolically stable analog of anandamide, 2-methyl-2′-F-anandamide (Met-F-AEA), inhibited the RHOA activity and caused a RHOA delocalization from the cell membrane to cytosol determining a decrease in actin stress fibers. Overexpression of a dominant negative of RHOA activity and treatment of these cells with a RHO-associated protein kinase (ROCK) inhibitor, Y 27632, mimicked Met-F-AEA effects on actin organization and cell migration. We suggest that the inhibitory effect of Met-F-AEA on tumor cell migration could be related to RHOA-ROCK-dependent signaling pathway.
Institute of Endocrinology e Experimental Oncology, Department of Biology and Cellular, Department of Pharmaceutical Sciences, National Institute of Digestive Diseases, CNR, Via Pansini 5, 80131 Naples, Italy
Search for other papers by Chiara Laezza in
Google Scholar
PubMed
Search for other papers by Anna Maria Malfitano in
Google Scholar
PubMed
Search for other papers by Maria Chiara Proto in
Google Scholar
PubMed
Search for other papers by Iolanda Esposito in
Google Scholar
PubMed
Search for other papers by Patrizia Gazzerro in
Google Scholar
PubMed
Search for other papers by Pietro Formisano in
Google Scholar
PubMed
Search for other papers by Simona Pisanti in
Google Scholar
PubMed
Search for other papers by Antonietta Santoro in
Google Scholar
PubMed
Search for other papers by Maria Gabriella Caruso in
Google Scholar
PubMed
Search for other papers by Maurizio Bifulco in
Google Scholar
PubMed
The endocannabinoid system regulates cell proliferation in human breast cancer cells. Recently, we described that a metabolically stable anandamide analog, 2-methyl-2′-F-anandamide, by activation of CB1 receptors significantly inhibited cell proliferation of human breast cancer cell lines. In this study, we observed that the activation of the CB1 receptor, in two human mammary carcinoma cell lines, MDA-MB-231 and MCF7, caused the inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity due to a reduction of HMG-CoA reductase transcript levels. The decrease of HMG-CoA reductase activity induced the inhibition of the prenylation of proteins, in particular of the farnesylation of Ras oncogenic protein involved in cell proliferation of these cell lines. We suggest that the inhibitory effect of anandamide analog on tumor cell proliferation could be related to the inhibition of Ras farnesylation.
